When is a biopsy-proven diagnosis necessary before stereotactic ablative radiotherapy for lung cancer?: A decision analysis.
about
Stereotactic body radiotherapy in lung cancer: an updatePrimary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC PatientsAn Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management.Is surgery still the best management option for early stage NSCLC?SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?Early lung cancer detection by low-dose CT screening: therapeutic implications.Solid pulmonary nodule risk assessment and decision analysis: comparison of four prediction models in 285 cases.Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation.Overdiagnosis in Lung Cancer Screening, Cost-Effectiveness of Computed Tomography Screening for Lung Cancer, and Decision Analysis of Need for Biopsy-proven Diagnosis before Stereotactic Ablative Radiotherapy for Lung Cancer.Cost-Effectiveness of Surveillance for Distant Recurrence in Extremity Soft Tissue Sarcoma.The great debate flashes: Surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer.British Thoracic Society guidelines for the investigation and management of pulmonary nodules.Image-based management of empiric lung stereotactic body radiotherapy (SBRT) without biopsy: Predictors from a 10-year single institution experience.
P2860
Q26781806-DEE78C67-113F-4833-960A-45B1C0920677Q26851601-39C9771C-3577-4ECF-B35A-662C5F714009Q33735718-E6ECBFD7-EAC1-4F42-A4A4-971431D81F56Q38390136-5E0E1EEB-839B-42D7-B52B-EE6EEF4B17C9Q38813253-4FE843A5-AA4C-4C0E-94FE-936EA9C6FEB9Q39049280-0B5AF975-3421-4FA8-A160-D57FE29516D2Q40233721-228D40E6-EEFD-4DA1-846E-444B331FFB01Q46035215-BD0119BB-6C31-44E4-AB85-D0082F0E36FEQ47941187-457B2C29-2D35-4DDA-AE43-FACBAD8BDC88Q48718890-60AC49CA-9B41-44F0-B47B-1B46141E4F68Q50138849-DCF01EF0-CEAF-474B-ACBC-F2010DCB1528Q51621075-423DFB67-C9F0-49F8-B0A7-59AC4A0716C9Q52716524-D625566B-C623-4A37-A3E8-96C10FB22E97
P2860
When is a biopsy-proven diagnosis necessary before stereotactic ablative radiotherapy for lung cancer?: A decision analysis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
When is a biopsy-proven diagno ...... cancer?: A decision analysis.
@en
When is a biopsy-proven diagno ...... cancer?: A decision analysis.
@nl
type
label
When is a biopsy-proven diagno ...... cancer?: A decision analysis.
@en
When is a biopsy-proven diagno ...... cancer?: A decision analysis.
@nl
prefLabel
When is a biopsy-proven diagno ...... cancer?: A decision analysis.
@en
When is a biopsy-proven diagno ...... cancer?: A decision analysis.
@nl
P2093
P50
P356
P1433
P1476
When is a biopsy-proven diagno ...... cancer?: A decision analysis.
@en
P2093
Alexander V Louie
David A Palma
Frank J Lagerwaard
George B Rodrigues
Joseph K Salama
Myriam G Hunink
Pretesh Patel
P304
P356
10.1378/CHEST.13-2924
P407
P577
2014-10-01T00:00:00Z